Our findings suggest that MWDT not only reduces CRC cell proliferation but also triggers ferroptosis through the PTK2B/STAT3/GPX4 axis, providing a potential new therapeutic strategy for the treatment of CRC. The gene discussed is GPX4; the disease is colorectal carcinoma.